Form 10-Q GALECTIN THERAPEUTICS For: Jun 30
Tweet
Share
E-mail
http://archive.fast-edgar.com/20140807/AI2LUQ2FZ22RVZZ2222C2ZXPB4DNZZ223262
Filed on: August 7, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MacroGenics to Receive Milestone Payment from Sanofi for Recent TZIELD® Approval
- Florida International University researchers reveal how altered images can bypass AI safeguards
- Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
